Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Zentalis Pharmaceuticals, Inc. (ZNTL) had Free Cash Flow per Share of $-0.46 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-48.28M |
|
-- |
|
-- |
|
$45.62M |
|
$-45.62M |
|
$-2.66M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-45.62M |
|
$-46.40M |
|
71.68M |
|
71.68M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$342.88M |
|
$3.25M |
|
$41.14M |
|
$384.02M |
|
$49.43M |
|
-- |
|
$39.21M |
|
$88.64M |
|
$295.38M |
|
$295.38M |
|
$295.38M |
|
71.95M |
|
| Cash Flow Statement Financials | |
$-32.64M |
|
$40.48M |
|
$0.19M |
|
$36.53M |
|
$44.56M |
|
$8.03M |
|
$6.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.34% |
|
-16.34% |
|
-12.57% |
|
-16.34% |
|
$4.11 |
|
|
Free Cash Flow per Share |
$-0.46 |
$-0.46 |
|